featured

April 20, 2022 Nexelis

Nexelis, a Q² Solutions Company, Wins Best Central/Speciality Laboratory Award at the 2022 Vaccine Industry Excellence Awards

We are celebrating this week as Nexelis has been recognized at the Vaccine Industry Excellence (ViE) awards, in Washington DC.

Read More

March 30, 2022 Admin

Where the Science Leads Us: SARS-CoV-2

By March 2020, when the World Health Organization declared SARS-CoV-2 a pandemic, every major multinational pharmaceutical company, innovative biotechnology company, governmental, and nongovernmental...

June 28, 2021 Admin

Where the Science Leads Us: Bispecific Antibodies

There’s a reason that Nexelis is the leading specialty lab for what’s next in therapeutic testing and assay development. Our corporate DNA is built from scientific rigor, premium facilities, and the...

June 28, 2021 Admin

Living History: Our Role in Global Scientific Collaboration for SARS-CoV-2

In this recent webinar, Bassam Hallis, Ph.D., Head of Preclinical Development for Public Health England, and Luc Gagnon, VP of Vaccine Sciences for Nexelis, discuss pandemic preparedness and response...